Advisory Alpha’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-200
Closed -$20K 207
2020
Q3
$20K Buy
+200
New +$20K ﹤0.01% 324
2020
Q2
Sell
-200
Closed -$10.5K 183
2020
Q1
$10.5K Hold
200
﹤0.01% 400
2019
Q4
$11.8K Hold
200
﹤0.01% 478
2019
Q3
$7.35K Buy
+200
New +$7.35K ﹤0.01% 494
2019
Q2
Sell
-200
Closed -$8K 217
2019
Q1
$8K Buy
+200
New +$8K ﹤0.01% 427